Get started
Author

Hélène Barraud

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
2017 · Valérie Vilgrain, Helena Pereira, et al. · The Lancet Oncology · 854
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
2014 · Thierry Thévenot, Christophe Bureau, et al. · Journal of Hepatology · 196
Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors
2020 · Thierry Artzner, Baptiste Michard, et al. · American Journal of Transplantation · 149
Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis
2010 · Didier Lebrec, Dominique Thabut, et al. · Gastroenterology · 137
PDF
Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma
2015 · Andres Huertas, Anne-Sophie Baumann, et al. · Radiotherapy and Oncology · 135
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results
2017 · Dominique Thabut, Arnaud Pauwels, et al. · Journal of Hepatology · 127
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
2021 · Pierre Nahon, Marie Najean, et al. · JHEP Reports · 61
PDF
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis
2021 · Jean-Frédéric Blanc, Faiza Khemissa, et al. · Hepatology International · 51
The epidemiology of Budd–Chiari syndrome in France
2018 · Isabelle Ollivier-Hourmand, Manon Allaire, et al. · Digestive and Liver Disease · 51
Covid-19 in liver transplant recipients: the French SOT COVID registry
2021 · Jérôme Dumortier, Christophe Duvoux, et al. · Clinics and Research in Hepatology and Gastroenterology · 48
PDF
French Intensive Care Society, International congress – Réanimation 2016
2016 · Jaillette, E, Girault, C, et al. · Annals of Intensive Care · 48
PDF
SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma
2017 · V. Vilgrain, M. Bouattour, et al. · Journal of Hepatology · 34
Effects of a B-vitamin-deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice
2007 · R. Lalonde, H. Barraud, et al. · Brain Research · 29
The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib
2017 · Guillaume Conroy, Julia Salleron, et al. · Oncotarget · 27
PDF
Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis
2013 · Jean Michel Petit, Samia Hamza, et al. · Acta Diabetologica · 26
Hépatotoxicité de la phytothérapie : données cliniques, biologiques, histologiques et mécanismes en cause pour quelques exemples caractéristiques
2004 · Laurent Peyrin-Biroulet, Hélène Barraud, et al. · Gastroentérologie Clinique et Biologique · 26
Hépatotoxicité probable du gallate d’épigallocatéchol utilisé en phytothérapie
2004 · Laurent Peyrin-Biroulet, Nadine Petitpain, et al. · Gastroentérologie Clinique et Biologique · 26
Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
2021 · Helena Pereira, Mohamed Bouattour, et al. · European Journal of Cancer · 21
PDF
Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients
2020 · Thomas Mouillot, Maud Rizk, et al. · Alimentary Pharmacology & Therapeutics · 20
Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study
2020 · Christophe Camus, Clara Locher, et al. · JGH Open · 18
PDF
BRIP1coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
2016 · Abderrahim Oussalah, for the CiRCE Study Group, et al. · Oncotarget · 17
PDF
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
2022 · Georges-Philippe Pageaux, Clovis Lusivika Nzinga, et al. · BMC Infectious Diseases · 16
PDF
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa
2008 · Jean-Pierre Bronowicki, Idrissia Abdelmouttaleb, et al. · Journal of Hepatology · 14
Perméabilité intestinale et cirrhose
2006 · David Ancel, Hélène Barraud, et al. · Gastroentérologie Clinique et Biologique · 14
Métabolisme des folates et cancérogenèse colorectale
2004 · Laurent Peyrin-Biroulet, Hélène Barraud, et al. · Gastroentérologie Clinique et Biologique · 11
Works count: 75
Citation count: 3,095
H-index: 20
I10-index: 27
Year
Topic
Type